Tag: Therapeutics
Breaking News
Aviceda Therapeutics Announces First Patient Dosed in Part 2 of the Phase 2/3 SIGLEC Clinical Trial Assessing AVD-104 for the Treatment of Geographic Atrophy
Part 2 of the Phase 2/3 SIGLEC clinical trial is designed and powered to serve as the first pivotal trial to support approval of...
Tevogen Bio Appoints Globally Prominent Physicist Specializing in Space Biology, COVID-19, and AI Democratization, Afshin Beheshti, to Advisory Board
The appointment of Afshin Beheshti, PhD, contributes to the diversity of thought leadership within Tevogen Bio by way of his roles as Bioinformatician and...
Cross-Border Impact Ventures Exceeds $90 Million in Final Close of Its Women’s and Children’s Health Technology Fund
Women-owned impact venture capital firm has made five investments to date in technology companies focused on women’s, children’s, and adolescents’ health
TORONTO–(BUSINESS WIRE)–Cross-Border Impact Ventures...
DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program
Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue.
COLUMBUS, Ohio–(BUSINESS WIRE)–#RNA–DNA Nanobots, a leader in the...
Bitcoin is coming for Gold’s global market, says Cathie Wood
The ARK Invest CEO says financial investors should go with crypto over the precious metal, and tech investors should stick with software.
Cathie...
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39%...
Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#CRISPR–Xcellerant Ventures is proud to announce its investment in CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first...
Nanowear Announces FDA 510(k) Clearance for AI-enabled Continuous Blood Pressure Monitoring and Hypertension Diagnostic Management: SimpleSense-BP
Utilizing patented nanosensors fueling transformative AI, SimpleSenseTM, is the first wearable platform that enables physicians to securely and accurately offer patients full routine cardiopulmonary...
We’re Inching Closer to Answers for Why We Age and How to Slow Down the Clock
Why do we age? And how can we slow down the clock?This year, we inched closer to answers. Longevity research continued decoding the core...
Fish & Richardson Elevates 20 Attorneys to Principal
MINNEAPOLIS–(BUSINESS WIRE)–Fish & Richardson is pleased to announce that 20 attorneys have been elevated to principal, effective January 1, 2024. This interdisciplinary class brings...
NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial
December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient...
USA Solid Tumor Therapeutics Market Outlook to 2028 – Field of Oncology is Moving Towards more Personalized Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Solid Tumor Therapeutics Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering.
The USA Solid Tumor Therapeutics Market refers to...
Latest Intelligence
